Andere Sprachen Zhejiang Medicine Co., Ltd.

Aktien

A0M390

CNE0000010J2

600216

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 27.06.2024			% 5 Tage	% 1. Jan.
10,91 ^CNY	-1,71 %		+11,44 %	+1,68 %

28.05.	China erteilt Zulassung für klinische Studie für antibakterielle Injektion von Zhejiang Medicine	MT
25.04.	Zhejiang Medicine Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

China Grants Clinical Trial Approval for Zhejiang Medicine's Antibacterial Injection	28.05.
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
Zhejiang Medicine Wins Nod to Trial Digestive Acid Drug	28.11.
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25.10.23
Zhejiang Medicine Wins Nod to Trial Anti-Tumor Drug	19.09.23
Zhejiang Medicine’s South Korean Unit Clears Good Manufacturing Practice Inspection	23.08.23
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23.08.23
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25.04.23
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25.04.23
Citic Securities says global financial market fluctuations hurt business	31.03.23
Zhejiang Medicine to Market Antibiotic in the US After Getting FDA Nod; Shares Jump 3%	30.01.23
Zhejiang Medicine Co., Ltd.(SHSE:600216) dropped from Shanghai Stock Exchange Health Care Sector Index	09.12.22
Zhejiang Medicine Unit Gets Clinical Trial Approval For Anti-Biliary Tract Cancer Drug	01.11.22
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26.10.22
Brokerage CLSA vice-chairman Charles Lin resigns	26.09.22
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25.08.22
Zhejiang Medicine Co., Ltd.(SHSE:600216) added to Shanghai Stock Exchange Health Care Sector Index	13.06.22
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26.04.22
TaiGen Biopharmaceuticals Turns to Profit in 2021	17.03.22
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	25.10.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zhejiang Medicine Co., Ltd.

Aktien

A0M390

CNE0000010J2

600216

Andere Sprachen

Filter